Charles Farkas

Charles Farkas

Director/Board Member at CONMED CORPORATION

Net worth: 554 314 $ as of 2026-05-30

74 year
Commercial Services
Consumer Services
Health Services

Profile

Charles M.
Farkas
is Chairman at Courtagen Life Sciences, Inc. and Medicinal Genomics Corp.
He is an Independent Director at CONMED Corp.
since 2014.
He serves as Director at NOWDiagnostics, Inc., The John A. Hartford Foundation, Inc., Sequel Youth & Family Services LLC, United Bridge Partners LP, and Intuitive Health LLC.
Formerly, Mr. Farkas was Managing Director at Bain & Co. Canada, Inc., Director at Harvard Medical School from 2005 to 2017, and Senior Partner & Global Head-Healthcare Practice at Bain & Co., Inc. Education includes undergraduate studies at Princeton University and an MBA from Harvard Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-01 15,527 ( 0.05% ) 554 314 $ 2026-05-30

Charles Farkas active positions

CompaniesPositionStart
CONMED CORPORATION Director/Board Member 2014-07-22
Director/Board Member -
Chairman -
Director/Board Member -
Chairman -
Director/Board Member -
Director/Board Member -
Director/Board Member -

Former positions of Charles Farkas

CompaniesPositionEnd
Director/Board Member 2016-12-31
░░░░ ░░░░░ ░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Charles Farkas's experience

Training of Charles Farkas

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

58

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Electronic Technology

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Health Services

Consumer Services

Health Services

Industrial Services

Consumer Services

Health Services

  1. Stock Market
  2. Insiders
  3. Charles Farkas
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!